Cargando…
Soluble CD147 (BSG) as a Prognostic Marker in Multiple Myeloma
CD147 (basigin, BSG) is a membrane-bound glycoprotein involved in energy metabolism that plays a role in cancer cell survival. Its soluble form is a promising marker of some diseases, but it is otherwise poorly studied. CD147 is overexpressed in multiple myeloma (MM) and is known to affect MM progre...
Autores principales: | Łacina, Piotr, Butrym, Aleksandra, Frontkiewicz, Diana, Mazur, Grzegorz, Bogunia-Kubik, Katarzyna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929000/ https://www.ncbi.nlm.nih.gov/pubmed/35723405 http://dx.doi.org/10.3390/cimb44010026 |
Ejemplares similares
-
BSG and MCT1 Genetic Variants Influence Survival in Multiple Myeloma Patients
por: Łacina, Piotr, et al.
Publicado: (2018) -
BSG (CD147) Serum Level and Genetic Variants Are Associated with Overall Survival in Acute Myeloid Leukaemia
por: Łacina, Piotr, et al.
Publicado: (2022) -
Telomere length and hTERT genetic variants as potential prognostic markers in multiple myeloma
por: Dratwa, Marta, et al.
Publicado: (2023) -
Cereblon and IRF4 Variants Affect Risk and Response to Treatment in Multiple Myeloma
por: Butrym, Aleksandra, et al.
Publicado: (2017) -
Genetic variation of the gene coding for microRNA-204 (miR-204) is a risk factor in acute myeloid leukaemia
por: Butrym, Aleksandra, et al.
Publicado: (2018)